Oncology & Immunology

Dr. María Linares and Dr. María Hernández are working with Ohmline to generate new treatments in different hematological tumors, with a special focus on multiple myeloma. They have already obtained promising preliminary results with Ohmline-based combination therapies which specifically target malignant cells, without compromising non-pathogenic T cells. 

Microbiology

Through a strategic partnering with the Portuguese company Bac3Gel, we are using Ohmline to encapsulate well-established antibiotics, overcoming resistance to them in the context of airborne bacterial infections. Ohmline-based combination therapies are tested in Bac3Gel’s innovative 3D culture systems, which optimally resemble the airway mucosa. This project is funded by CDTI (MultiPaís 2024 program).